Prognostic Value of the Geriatric Nutritional Risk Index in Previously Untreated Patients With Advanced NSCLC Treated With a Combination Therapy of Anti-PD-1/-PD-L1 Antibodies and Platinum-Based Chemotherapy: A Multicenter Retrospective Study

CONCLUSION: The present study demonstrates that the GNRI is a useful prognostic predictor in patients with NSCLC treated with a combination therapy of anti-PD-1/-PD-L1 antibodies and platinum-based chemotherapy in clinical settings.PMID:38320539 | DOI:10.1159/000536120

Source: Oncology - February 6, 2024 Category: Cancer & Oncology Authors: Taro Hirabayashi Kei Sonehara Ryota Ozawa Tsutomu Hachiya Shuhei Nozawa Toshihiko Agatsuma Hiroshi Yamamoto Akane Kato Akemi Matsuo Taisuke Araki Masamichi Komatsu Kazunari Tateishi Masayuki Hanaoka Source Type: research